Pfizer expects to produce 80 mn courses of Covid-19 antiviral pill: Report

Earlier this month, Pfizer said it expects to manufacture 180,000 treatment courses by the end of this year and at least 50 mn courses by the end of next year, including 21 mn in the first half of 2022

Pfizer expects to produce 80 mn courses of Covid-19 antiviral pill: Report
Earlier this month, Pfizer said it expects to manufacture 180,000 treatment courses by the end of this year and at least 50 mn courses by the end of next year, including 21 mn in the first half of 2022